Stay updated with breaking news from Ruby Trial. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Mansoor R. Mirza, MD, reviews data from the phase 3 RUBY trial investigating dostarlimab in combination with carboplatin and paclitaxel for the treatment of primary advanced or recurrent endometrial cancer.
Combining the immune checkpoint inhibitor dostarlimab-gxly with standard-of-care chemotherapy elicited an increase in progression-free survival rates compared with chemotherapy alone for patients with primary advanced or recurrent endometrial cancer.
Mansoor Raza Mirza, MD, discusses findings from the phase 3 RUBY trial in patients with endometrial cancer.
Dostarlimab plus standard-of-care chemotherapy generated a significant improvement in progression-free survival vs chemotherapy alone for patients with recurrent endometrial cancer, including those with mismatch repair–deficient, microsatellite instability–high tumors.
Donald trump in the news cycle every day, you're seeing a decrease in the amount of people clicking on stories, watching cable news, et cetera. >> originally i booked you here dan to talk about the new book "kennedy avenge". >> frankly there was a lot i didn't know until i opened this up. so i wonder, since your book shows that a lot of jfk conspiracies stemmed from the ruby trial, are there lessons from those conspiracy theories in the '60s to today. >> i think it is a lot about what we're talking about, right. in the book we give examples of times when things were left unanswered. the defens...